Marks, Kristen

Publications

Sort by

Co-Author Network

selected publications

Assessing routes of hepatitis C transmission in HIV-infected men who have sex with men using single genome sequencing. PloS one. 2020 Academic Article GET IT
Ledipasvir/Sofosbuvir for 8 Weeks to Treat Acute Hepatitis C Virus Infections in Men With Human Immunodeficiency Virus Infections: Sofosbuvir-Containing Regimens Without Interferon for Treatment of Acute HCV in HIV-1 Infected Individuals. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2019 Academic Article GET IT
Times cited: 4
Management of Hepatitis C in 2019. JAMA. 2019 Article GET IT
Times cited: 8
Benefit of Early versus Deferred Antiretroviral Therapy on Progression of Liver Fibrosis among People with HIV in the START Randomized Trial. Hepatology (Baltimore, Md.). 2019 Academic Article GET IT
Times cited: 2
Management of hepatitis B and C infections in rheumatologic disease. Best practice & research. Clinical rheumatology. 2018 Review GET IT
Times cited: 1
Effects of sofosbuvir-based hepatitis C treatment on the pharmacokinetics of tenofovir in HIV/HCV-coinfected individuals receiving tenofovir disoproxil fumarate. The Journal of antimicrobial chemotherapy. 2018 Academic Article GET IT
Times cited: 5
Hepatitis C Management Simplification From Test to Cure: A Framework for Primary Care Providers. Clinical therapeutics. 2018 Academic Article GET IT
Times cited: 11
Hepatitis C Treatment Outcomes for People Who Inject Drugs Treated in an Accessible Care Program Located at a Syringe Service Program. Open forum infectious diseases. 2018 Academic Article GET IT
Times cited: 15
The albumin-bilirubin grade uncovers the prognostic relationship between hepatic reserve and immune dysfunction in HIV-associated hepatocellular carcinoma. Alimentary pharmacology & therapeutics. 2017 Academic Article GET IT
Times cited: 7
Risk factors for hepatitis C seropositivity among young people who inject drugs in New York City: Implications for prevention. PloS one. 2017 Academic Article GET IT
Times cited: 23
Sofosbuvir Plus Ribavirin Without Interferon for Treatment of Acute Hepatitis C Virus Infection in HIV-1-Infected Individuals: SWIFT-C. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2017 Academic Article GET IT
Times cited: 23
Phase 3 trial of first generation protease inhibitor therapy for hepatitis C virus/human immunodeficiency virus coinfection. World journal of hepatology. 2017 Academic Article GET IT
Times cited: 2
Do directly acting antiviral agents for HCV increase the risk of hepatic decompensation and decline in renal function? Results from ERCHIVES. Alimentary pharmacology & therapeutics. 2016 Academic Article GET IT
Times cited: 27
Herpes Simplex Virus Hepatitis in an Immunocompetent Host Resembling Hepatic Pyogenic Abscesses. Case reports in hepatology. 2016 Academic Article GET IT
Adding ribavirin to newer DAA regimens does not affect SVR rates in HCV genotype 1 infected persons: results from ERCHIVES. Alimentary pharmacology & therapeutics. 2016 Academic Article GET IT
Times cited: 10
The Risk of Cardiovascular Disease, Diabetes, Liver-Related Outcomes, and Death Over 10 Years in HIV/HCV-Coinfected Patients With and Without Steatosis. AIDS research and human retroviruses. 2016 Academic Article GET IT
Times cited: 6
Hepatitis C guidance: AASLD-IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus. Hepatology (Baltimore, Md.). 2015 Academic Article GET IT
Times cited: 852
Ledipasvir and Sofosbuvir for HCV in Patients Coinfected with HIV-1. The New England journal of medicine. 2015 Academic Article GET IT
Times cited: 326
Addition of nitazoxanide to PEG-IFN and ribavirin to improve HCV treatment response in HIV-1 and HCV genotype 1 coinfected persons naïve to HCV therapy: results of the ACTG A5269 trial. HIV clinical trials. 2013 Academic Article GET IT
Times cited: 4
Depression and fatigue in chronic hepatitis C patients with and without HIV co-infection. Psychosomatics. 2013 Academic Article GET IT
Times cited: 11
Rapid progression to decompensated cirrhosis, liver transplant, and death in HIV-infected men after primary hepatitis C virus infection. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2012 Academic Article GET IT
Times cited: 42
The first wave: HCV NS3 protease inhibitors telaprevir and boceprevir. Antiviral therapy. 2012 Review GET IT
Times cited: 26
Clonal B cells in patients with hepatitis C virus-associated mixed cryoglobulinemia contain an expanded anergic CD21low B-cell subset. Blood. 2011 Academic Article GET IT
Times cited: 125
Risk factors for thrombocytopenia in HIV-infected persons in the era of potent antiretroviral therapy. Journal of acquired immune deficiency syndromes (1999). 2009 Academic Article GET IT
Times cited: 33
Autoimmune hepatitis in the HIV-infected patient: a therapeutic dilemma. AIDS patient care and STDs. 2009 Academic Article GET IT
Times cited: 16
Understanding the pathogenesis and management of hepatitis B/HIV and hepatitis B/hepatitis C virus coinfection. Clinics in liver disease. 2007 Review GET IT
Times cited: 13
Presentation and outcome of hepatocellular carcinoma in HIV-infected patients: a U.S.-Canadian multicenter study. Journal of hepatology. 2007 Academic Article GET IT
Times cited: 176
New Antiretroviral Agents for the Treatment of HIV Infection. Current infectious disease reports. 2004 Academic Article GET IT
New antiretroviral agents for the treatment of HIV infection. Current HIV/AIDS reports. 2004 Review GET IT
Times cited: 6

more ...

less ...

Research

Sort by

Co-investigator Network

Funding awarded

Research Training in Infectious Diseases awarded by National Institute of Allergy & Infectious Diseases Co-Investigator 2020 - 2025
Weill Cornell Medical College-New Jersey Medical School Clinical Trials Unit awarded by National Institute of Allergy & Infectious Diseases Co-Investigator 2013 - 2020

CoVPN 3004: Phase 3, SARS-CoV-2 Vaccine (Novavax) awarded by National Institute of Allergy & Infectious Diseases Principal Investigator Subaward 2020 - 2022
CoVPN 3001: Phase 3, SARS-CoV-2 Vaccine (Moderna TX, Inc.) awarded by National Institute of Allergy & Infectious Diseases Principal Investigator Subaward 2020 - 2022
Accessible Care Intervention for Engaging People who Inject Illicit Drugs (PWID) in Hepatitis C Care awarded by National Institute on Minority Health & Health Disparities Principal Investigator Subaward 2019 - 2021
Effect of Pitavastatin on Kidney Function in HIV-infected Persons - CRS 7804 1560 B XA868 awarded by National Institute of Allergy & Infectious Diseases Principal Investigator Subaward 2018 - 2021
CoVPN Vaccine Site Preparation - WCM Uptown and Chelsea awarded by National Institute of Allergy & Infectious Diseases Principal Investigator Subaward 2020 - 2020
Leadership and Operations Center (LOC), AIDS Clinical Trials Group (ACTG) [UM1AI068636] - A5379 Protocol co-Chair Principal Investigator Subaward 2018 - 2020
Leadership and Operations Center (LOC), AIDS Clinical Trials Group (ACTG) [UM1AI068636] - PF CRS 7804 1560 B WA820 Principal Investigator Subaward 2018 - 2020

more ...

less ...

Background

education and training

M.S., Weill Cornell Graduate School of Medical Sciences 2009
M.D., Columbia University College of Physicians and Surgeons 1999
B.A., M.S., Stanford University 1995

Contact

full name

Kristen Marks

primary email

markskr@med.cornell.edu

webpage

Clinical Profile

VIVO Weill Cornell Medical College

Kristen Marks Associate Professor of Medicine

Publications

selected publications

Research

Funding awarded

Background

education and training

Contact

full name

primary email

webpage

Phone

Publications

selected publications

Research

Funding awarded

Background

education and training

Contact

full name

primary email

webpage